| Data | Ora | Fonte | Titolo | Simbolo | Compagnia |
| 12/07/2022 | 14:36 | InvestorsHub NewsWire | Oncology Pharma Conducting Interviews and Presentations with Investors to Pursue Next Steps to Forward The Development Process of Nanoemulsion Drug Delivery System | USOTC:ONPH | Oncology Pharma Inc (CE) |
| 29/06/2022 | 15:23 | InvestorsHub NewsWire | Oncology Pharma Conducting All The Preparations to Take Steps to Forward The Development Process of Nanoemulsion Drug Delivery System | USOTC:ONPH | Oncology Pharma Inc (CE) |
| 08/06/2022 | 14:17 | InvestorsHub NewsWire | Oncology Pharma Announces: Initial Feasibility Study of the Nanoemulsion Drug Delivery System is Complete and Results Have Met the Threshold for Moving Forward To the Next Steps of Development | USOTC:ONPH | Oncology Pharma Inc (CE) |
| 09/05/2022 | 14:48 | InvestorsHub NewsWire | Oncology Pharma Advances Progress on Multiple Fronts Including Advanced Attention to Connect2Trials' Commercial Development | USOTC:ONPH | Oncology Pharma Inc (CE) |
| 13/04/2022 | 14:45 | InvestorsHub NewsWire | Oncology Pharma Completes Feasibility Phase of its Licensed Nanoemulsion Drug Delivery System to Treat Cancer | USOTC:ONPH | Oncology Pharma Inc (CE) |
| 02/03/2022 | 14:03 | InvestorsHub NewsWire | Oncology Pharma Reports on Progress with Ribera Solutions | USOTC:ONPH | Oncology Pharma Inc (CE) |
| 23/02/2022 | 14:00 | InvestorsHub NewsWire | Oncology Pharma Releases Further Feasibility Studies, Data and Capacities | USOTC:ONPH | Oncology Pharma Inc (CE) |
| 17/02/2022 | 14:16 | InvestorsHub NewsWire | Oncology Pharma Expands on Feasibility Studies and Data | USOTC:ONPH | Oncology Pharma Inc (CE) |
| 14/02/2022 | 14:11 | InvestorsHub NewsWire | Oncology Pharma, Inc. and Regen BioPharma, Inc. Announce Intent to Jointly Fast Track Development of Modified mRNA anti-Cancer Vaccine | USOTC:ONPH | Oncology Pharma Inc (CE) |
| 08/02/2022 | 14:30 | InvestorsHub NewsWire | Oncology Pharma Gives Update on Technology, Formulation and Data Creation | USOTC:ONPH | Oncology Pharma Inc (CE) |
| 10/01/2022 | 14:15 | InvestorsHub NewsWire | Oncology Pharma's New Year Update | USOTC:ONPH | Oncology Pharma Inc (CE) |
| 17/12/2021 | 14:11 | InvestorsHub NewsWire | Oncology Pharma Meeting Towards Future Developments | USOTC:ONPH | Oncology Pharma Inc (CE) |
| 09/12/2021 | 14:04 | InvestorsHub NewsWire | Oncology Pharma Year End Review and Outlook | USOTC:ONPH | Oncology Pharma Inc (CE) |
| 30/11/2021 | 14:02 | InvestorsHub NewsWire | Oncology Pharma Research and Vision | USOTC:ONPH | Oncology Pharma Inc (CE) |
| 08/11/2021 | 14:00 | InvestorsHub NewsWire | Oncology Pharma Reveals Plans for Development of Lead Cancer Drug Candidate | USOTC:ONPH | Oncology Pharma Inc (CE) |
| 28/10/2021 | 17:11 | InvestorsHub NewsWire | Oncology Pharma, Inc. Gives Update on Ongoing Work and Progress | USOTC:ONPH | Oncology Pharma Inc (CE) |
| 16/10/2021 | 02:12 | StockInvest.us | High volatility in Oncology Pharma Inc. stock price on Friday which ended trading at $13.95 | USOTC:ONPH | Oncology Pharma Inc (CE) |
| 15/10/2021 | 16:51 | InvestorsHub NewsWire | Oncology Pharma, Inc. Has Engaged a PCAOB Audit Firm Looking Towards Moving the Company Towards a Senior Listing | USOTC:ONPH | Oncology Pharma Inc (CE) |
| 12/10/2021 | 14:30 | InvestorsHub NewsWire | Oncology Pharma, Inc. Update on PCAOB Audit Selection Process and License Agreement | USOTC:ONPH | Oncology Pharma Inc (CE) |
| 05/10/2021 | 02:09 | StockInvest.us | Big movements in Oncology Pharma Inc. stock price on Monday moving 40.14% between high and low | USOTC:ONPH | Oncology Pharma Inc (CE) |
| 17/09/2021 | 02:08 | StockInvest.us | High volatility in Oncology Pharma Inc. stock price on Thursday which ended trading at $11.35 | USOTC:ONPH | Oncology Pharma Inc (CE) |
| 13/09/2021 | 14:30 | InvestorsHub NewsWire | Oncology Pharma, Inc. Has Received the Committed Funding to Perform All Necessary IND-Enabling Preclinical Work for Its First Lead Candidate, a Dactinomycin Nanoemulsion Drug Product | USOTC:ONPH | Oncology Pharma Inc (CE) |
| 27/08/2021 | 02:08 | StockInvest.us | High volatility in Oncology Pharma Inc. stock price on Thursday which ended trading at $20.38 | USOTC:ONPH | Oncology Pharma Inc (CE) |
| 26/08/2021 | 02:12 | StockInvest.us | Volatile ride for Oncology Pharma Inc. stock price on Wednesday moving between $14.02 and $17.99 | USOTC:ONPH | Oncology Pharma Inc (CE) |
| 25/08/2021 | 02:09 | StockInvest.us | Big movements in Oncology Pharma Inc. stock price on Tuesday moving 10.33% between high and low | USOTC:ONPH | Oncology Pharma Inc (CE) |
| 24/08/2021 | 02:10 | StockInvest.us | High volatility in Oncology Pharma Inc. stock price on Monday which ended trading at $15.00 | USOTC:ONPH | Oncology Pharma Inc (CE) |
| 23/08/2021 | 14:30 | InvestorsHub NewsWire | Oncology Pharma's Co-Development Agreement Pursues Strategic and Direct Objectives | USOTC:ONPH | Oncology Pharma Inc (CE) |
| 21/08/2021 | 02:10 | StockInvest.us | High volatility in Oncology Pharma Inc. stock price on Friday which ended trading at $15.42 | USOTC:ONPH | Oncology Pharma Inc (CE) |
| 19/08/2021 | 14:00 | InvestorsHub NewsWire | Oncology Pharma, Inc. Executes Co-Development Agreement with NanoSmart Pharmaceuticals, Inc. | USOTC:ONPH | Oncology Pharma Inc (CE) |
| 13/08/2021 | 02:11 | StockInvest.us | Red day on Thursday for Oncology Pharma Inc. | USOTC:ONPH | Oncology Pharma Inc (CE) |
